Visioneering Technologies, Inc. and Lambda-X Develop Software to Show Accurate Power Profile of NaturalVue Multifocal Contact Lenses

ATLANTA--(BUSINESS WIRE)--US-based medical device company and inventor of the NaturalVue® (etafilcon A) Multifocal 1 Day Contact Lenses, Visioneering Technologies, Inc (ASX: VTI) (‘VTI’ or ‘The Company’) has released additional data regarding its patented NaturalVue® Multifocal (etafilcon A) 1 Day Contact Lens. Scientific Interest Practitioners employing VTI’s NaturalVue Multifocal in managing myopia in children recently announced updated data demonstrating in 141 children that wearing NaturalV

Full Story →